New study aims to find best painkiller for c-section recovery

NCT ID NCT07170267

Recruiting now Symptom relief Sponsor: Tanta University Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study compares two ways to manage pain after a C-section: a nerve block (TFP block) and a medication added to spinal anesthesia (intrathecal dexmedetomidine). Fifty women undergoing planned C-sections will be randomly assigned to one of the two methods. Researchers will measure pain levels and how much extra pain medicine is needed over the first 24 hours after surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: bupivacaine and dexmedetomidine
What this could lead to: If this trial succeeds, it could point to a better way to manage pain after C-section, reducing the need for strong painkillers like morphine.
What could go wrong: This is a small, early-stage study with only 50 participants, so results may not apply to everyone. Both methods have risks like infection or side effects from the medications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CESAREAN SECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CESAREAN SECTION INTRATHECAL DEXMEDETOMIDINE TRANSVERSALIS FASCIA PLANE BLOCK

Contacts and locations

Locations

Tanta University
RECRUITING

Tanta, El-Gharbia, 31527, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.